![]() |
|
|
Co-operative Research Centre for Food Industry Innovation, CSIRO (Australia) Division of Human Nutrition, Adelaide 5000, Australia
Twelve young male pigs consumed a purified diet containing wheat bran as fiber source. Starch provided 50% of total daily energy either as a low amylose cornstarch or as a high amylose (amylomaize) starch. The pigs were given a supplement of a freeze-dried probiotic organism (Bifidobacterium longum CSCC 1941). A block crossover design was used so that at any one time two groups of three pigs consumed either the high or low amylose cornstarch without probiotic and a further two groups of three pigs consumed either high or low amylose cornstarch with probiotic. Neither food intake nor body weight gain was affected by diet. Fecal output was higher when pigs were fed the high amylose cornstarch, but moisture content was unaffected. Fecal concentrations and excretion of total volatile fatty acids were higher when pigs were fed the high amylose cornstarch. Concentrations of acetate were unaffected by dietary starch, but those of propionate and butyrate were higher when the high amylose cornstarch was consumed. Fecal excretion of all three acids was higher during high amylose cornstarch feeding. Bifidobacteria were detected in the feces only when pigs were fed Bifidobacterium longum. Fecal bifidobacteria counts (expressed per gram of wet feces) and their daily fecal excretion were higher when pigs were fed high amylose cornstarch. Feeding the probiotic did not alter fecal starch or volatile fatty acids. None of the variables studied was affected by the order of feeding of starch or probiotic. The data show that a high amylose starch acts as a prebiotic in promoting the fecal excretion of probiotic organisms.
KEY WORDS: pigs · prebiotics · probiotics · starch · volatile fatty acidsProbiotic microorganisms (Lactobacillus sp., Bifidobacterium sp. and others) have been defined as live microbial food supplements that affect the host animal beneficially by improving its intestinal microbial balance (Fuller 1989
). It has been suggested that probiotics may be of therapeutic or preventative benefit for a number of pathological states, including gastroenteritis, diarrhea, constipation and hypercholesterolemia (Goldin and Gorbach 1992
). Consumption of yogurt containing Bifidobacterium longum lowers the frequency of antibiotic-induced gastrointestinal disorders (Colombel et al. 1987
). Experimental studies in mice fed bifidobacteria have shown lower numbers of chemically induced tumors in the large bowel (Koo and Rao 1991
), which is consistent with a possible reduction in the risk of cancer in that viscus. These and other observations indicate that probiotics have the potential to improve human colonic health (Playne 1995
).
While these data are suggestive of benefit from the standpoint of disease reduction and health promotion, a number of criteria need to be met before increased consumption of probiotics can be recommended to the general population. One of these is survival of the live organisms in the gastrointestinal tract. The large bowel is the major site of bacterial colonization and metabolism in the human gut and contains a wide range of species. These include bacteria that metabolize dietary carbohydrates to volatile fatty acids (VFA)7 that are thought to mediate some of the health benefits normally ascribed to the carbohydrates themselves. (Annison and Topping 1994
, Cummings and Macfarlane 1991
) These actions include stimulation of electrolyte and fluid transport, enhancement of colonic muscular activity and promotion of a normal cell phenotype in colonocytes. Potentially pathogenic species such as clostridia and coliforms also reside in the large bowel and may proliferate and produce adverse reactions (Tancrede 1992
). The hind gut is the region where probiotics could be expected to colonize and where some of their beneficial actions could originate, e.g., through altering of VFA profiles. Studies of the effects of probiotics on VFA excretion have been inconclusive and Bartram et al. (1995) noted that the fecal flora and VFA excretion of normal humans were extremely stable with respect to dietary perturbation through ingestion of live B. longum. These authors attempted to enhance the survival of the probiotic culture by adding lactulose as a metabolic substrate for the bifidobacteria. This illustrates the concept of prebiotics, which are nondigestible food ingredients that affect the host beneficially by selectively stimulating the growth and/or activity of one or a limited number of bacteria in the colon and thus improving host health (Gibson and Roberfroid 1995
). Certain oligosaccharides are used selectively by probiotic microorganisms, and the fructo-oligosaccharides seem to act as prebiotics in humans (Gibson et al. 1995
). Other, nutritionally important, complex carbohydrates including starches and nonstarch polysaccharides (NSP) have been viewed as having a low potential as prebiotics (Gibson and Roberfroid 1995
). In the case of starches, this is understandable because they may be digested completely by human digestive enzymes, in contrast to fructo- and galacto-oligosaccharides and NSP, which are resistant. However, it seems that this is an oversimplification because a large proportion of starch escapes small intestinal digestion and enters the large bowel, where it is fermented by the bacteria, yielding VFA (Cummings and Macfarlane 1991
). This so-called resistant starch (RS) arises for a variety of reasons, including cooking, the presence of NSP and the degree of mastication (Annison and Topping 1994
). Of particular interest is the fact that a high amylose content in corn lowers the small intestinal enzymic hydrolysis of the starch. Feeding trials with high amylose starch in humans have shown loss of starch from the ileum (Muir et al. 1994
) and studies in pigs have shown increased starch concentrations in the proximal colon (Topping et al. 1997
). Fecal VFA excretion is higher in humans consuming high amylose starch (Noakes et al., 1996
) or another RS manufactured by a commercial process (van Munster et al. 1994
). These changes are consistent with enhanced large bowel bacterial fermentation and we considered it possible that RS might act as a prebiotic. This hypothesis runs contrary to current opinion and was tested by examining the fecal excretion of bifidobacteria in pigs fed freeze-dried Bifidobacterium longum with a high amylose starch. In view of the fact that important health benefits of RS (and NSP) are mediated through VFA, we examined the effect of feeding this probiotic on fecal VFA as an index of their production by the colonic microflora.
-amylase method; Megazyme Ltd, Sydney, NSW, Australia). The bacteriological examination of feces was performed within 2 h of collection. A 10-g sample of feces was suspended homogenously in 1% buffered peptone and was further diluted in 10-fold dilutions. Of the appropriate dilutions, 0.1 mL was plated in duplicate onto the surface of Bifidus Blood Agar (Pachenari et al. 1997|
Table 1. Fecal concentrations and daily excretion of bifidobacteria of pigs fed either a low amylose or high amylose (amylomaize) cornstarch with live Bifidobacterium longum1 |
|
Table 2. Fecal concentrations of volatile fatty acids (VFA) of pigs fed either a low amylose or high amylose (amylomaize) cornstarch with or without live Bifidobacterium longum1 |
|
Table 3. Fecal pools of volatile fatty acids (VFA) of pigs fed either a low amylose or high amylose (amylomaize) cornstarch with or without live Bifidobacterium longum1 |
were the first to show in humans that the increase in fecal bulk due to dietary fiber consumption was due to greater bacterial numbers as well as excretion of NSP and lignin. In the present experiment, fecal bifidobacteria numbers expressed per unit fecal weight were higher when the probiotic was fed with RS. We could not distinguish between the B. longum that was fed and other bifidobacteria species. However, it is likely that the increase reflected greater growth of the bacteria administered orally, because no bifidobacteria were detected in pigs when they were not fed the supplement. Possibly, this could reflect the presence of antibiotic in the standard ration and also the lability of bifidobacteria colonization of the gut. The latter possibility has been confirmed in a subsequent experiment in pigs in which we used the same design as in the present study. In this subsequent experiment, the standard ration was manufactured from the same ingredients but without the antibiotic. In that experiment, the fecal bifidobacteria numbers and total excretion were comparable to those found in pigs fed the low and high amylose cornstarches in this study (Bird, A. R., Warhurst, M., Crittenden, R., Hayakawa, T., Playne, M. J., Illman, R. J., Brown, I. L. and Topping, D. L., unpublished observations). Other variables (including stool mass and fecal VFA) were similar, indicating that the inclusion of olaquindox did not influence the outcome. In that experiment, fecal bifidobacteria declined within a few days of stopping the feeding of live organisms when the diet contained low amylose starch, but the decline was much slower when high amylose starch was fed.
, the high amylose starch acted as a prebiotic even though these authors concluded that starches were unlikely to perform this function. However, the increase in fecal mass noted in this experiment was of such a magnitude as to suggest that the feeding of high amylose cornstarch increased the numbers of other bacterial species as well as the probiotic organisms.
, Muir et al. 1994
, Topping et al. 1997
). This is supported by the observation that alginate, which is not degraded by human small intestinal enzymes, raises fecal bifidobacteria in humans (Terada et al. 1996
). However, the fact that other NSP, which also affect the dynamics of the small intestine, do not seem to act as prebiotics tends to make this possibility less likely. Secondly, the bacteria may have been protected by adhesion to undigested starch or through entry into the pits formed in the starch granules during small intestinal amylolysis (Topping et al. 1997
). A final possible mechanism is that the high amylose starch was simply a substrate for the bifidobacteria. Generally, it is thought that bifidobacteria do not metabolize starches efficiently (Sgorbati et al. 1995
). This is supported by the lack of difference in fecal starch excretion between pigs fed RS alone and those fed RS with probiotic.
) and pigs (Topping et al. 1997
), the fecal concentrations of VFA were higher in pigs fed high amylose cornstarch. Also as in other previous studies, VFA excretion was higher during the feeding of a high amylose starch (Mazur et al. 1990
, Noakes et al. 1996
) and another RS (van Munster et al. 1994
). These differences are consistent with enhanced large bowel bacterial fermentation through provision of extra substrate. As we have noted recently in pigs (Topping et al., 1997
), fecal acetate, propionate and butyrate were raised during consumption of high amylose starch. This differs from findings in humans and rats in which feeding of RS raises fecal butyrate more than the other acids (Mazur et al. 1990
, Noakes et al. 1996
, van Munster et al. 1994
), apparently through the preferential production of this acid during bacterial starch fermentation (Weaver et al. 1992
). Butyrate is thought to exert protective effects on the colonic mucosa, including a diminished risk of neoplasms (Kruh et al. 1994
). Epidemiologic data suggest a protective role for greater starch consumption in colorectal carcinogenesis (Cassidy et al. 1994
) and one attractive possibility is through fermentation of starch to butyrate. However, there seems to be a species difference between pigs on the one hand and humans and rats on the other. The reason for the difference may lie in the bacterial population present in the gut or in the physiology of the gut itself. The cecum and colon are a larger proportion of the total gastrointestinal tract in pigs compared with humans and other model species such as rats and dogs (van Soest 1995). Given that butyrate is used preferentially by colonocytes and that its supply may be limiting to utilization (Illman and Topping 1986
), it is possible that any increase in its production could be offset by increased utilization. Alternatively, it may be an effect of the type of starch, because the feeding of brown rice to pigs increases the large bowel pool of butyrate, apparently through the fermentation of starch (Marsono et al. 1993
).
, there was no effect of probiotic ingestion on either total or individual VFA excretion when fed with either starch even though bifidobacteria numbers were higher when pigs consumed RS. However, it must be noted that fecal excretion is a net process and represents a balance between production and utilization. Studies in pigs have shown that the distribution of digesta and VFA along the large bowel cannot be predicted from values in the distal colon (Topping et al. 1993
). More recently, Bartram and co-workers (1994) made a similar suggestion and proposed that there may be changes in VFA in the proximal bowel that might not be detected in the distal colon or feces. However, most degenerative bowel disease is expressed in the distal colon, suggesting that, if probiotic organisms were to be protective against them, VFA are not the likely mediators.
). In addition to this health benefit it has been noted that RS may offer a technological advantage in that their presence in human foods raises their content of "fiber" without necessarily altering their organoleptic properties (Annison and Topping 1994
). In the case of high amylose starches, their capacity to act as prebiotics seems to extend the scope for their use in food so as to enhance delivery of probiotic microorganisms to the distal bowel.
Manuscript received 29 January 1997. Initial reviews completed 24 February 1997. Revision accepted 20 May 1997.
This article has been cited by other articles:
![]() |
K. L. Conn, E. Topp, and G. Lazarovits Factors Influencing the Concentration of Volatile Fatty Acids, Ammonia, and Other Nutrients in Stored Liquid Pig Manure J. Environ. Qual., January 25, 2007; 36(2): 440 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Ryan, G. F. Fitzgerald, and D. van Sinderen Screening for and Identification of Starch-, Amylopectin-, and Pullulan-Degrading Activities in Bifidobacterial Strains Appl. Envir. Microbiol., August 1, 2006; 72(8): 5289 - 5296. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Loh, M. Eberhard, R. M. Brunner, U. Hennig, S. Kuhla, B. Kleessen, and C. C. Metges Inulin Alters the Intestinal Microbiota and Short-Chain Fatty Acid Concentrations in Growing Pigs Regardless of Their Basal Diet J. Nutr., May 1, 2006; 136(5): 1198 - 1202. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gajda, E. A. Flickinger, C. M. Grieshop, L. L. Bauer, N. R. Merchen, and G. C. Fahey Jr. Corn hybrid affects in vitro and in vivo measures of nutrient digestibility in dogs J Anim Sci, January 1, 2005; 83(1): 160 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Moreau, M. M. Champ, S. M. Goupry, B. J. Le Bizec, M. Krempf, P. G. Nguyen, H. J. Dumon, and L. J. Martin Resistant Starch Modulates In Vivo Colonic Butyrate Uptake and Its Oxidation in Rats with Dextran Sulfate Sodium-Induced Colitis J. Nutr., March 1, 2004; 134(3): 493 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Le Leu, I. L. Brown, Y. Hu, and G. P. Young Effect of resistant starch on genotoxin-induced apoptosis, colonic epithelium, and lumenal contents in rats Carcinogenesis, August 1, 2003; 24(8): 1347 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Mikkelsen, C. Bendixen, M. Jakobsen, and B. B. Jensen Enumeration of Bifidobacteria in Gastrointestinal Samples from Piglets Appl. Envir. Microbiol., January 1, 2003; 69(1): 654 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Martinez-Puig, J. F. Perez, M. Castillo, A. Andaluz, M. Anguita, J. Morales, and J. Gasa Consumption of Raw Potato Starch Increases Colon Length and Fecal Excretion of Purine Bases in Growing Pigs J. Nutr., January 1, 2003; 133(1): 134 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.K. Le Leu, Y. Hu, and G.P. Young Effects of resistant starch and nonstarch polysaccharides on colonic luminal environment and genotoxin-induced apoptosis in the rat Carcinogenesis, May 1, 2002; 23(5): 713 - 719. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kishida, H. Nogami, S. Himeno, and K. Ebihara Heat Moisture Treatment of High Amylose Cornstarch Increases Its Resistant Starch Content but Not Its Physiologic Effects in Rats J. Nutr., October 1, 2001; 131(10): 2716 - 2721. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Crittenden, A. Laitila, P. Forssell, J. Matto, M. Saarela, T. Mattila-Sandholm, and P. Myllarinen Adhesion of Bifidobacteria to Granular Starch and Its Implications in Probiotic Technologies Appl. Envir. Microbiol., August 1, 2001; 67(8): 3469 - 3475. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Topping and P. M. Clifton Short-Chain Fatty Acids and Human Colonic Function: Roles of Resistant Starch and Nonstarch Polysaccharides Physiol Rev, July 1, 2001; 81(3): 1031 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Lopez, M.-A. Levrat-Verny, C. Coudray, C. Besson, V. Krespine, A. Messager, C. Demigné, and C. Rémésy Class 2 Resistant Starches Lower Plasma and Liver Lipids and Improve Mineral Retention in Rats J. Nutr., April 1, 2001; 131(4): 1283 - 1289. [Abstract] [Full Text] |
||||
![]() |
I. Wollowski, G. Rechkemmer, and B. L Pool-Zobel Protective role of probiotics and prebiotics in colon cancer Am. J. Clinical Nutrition, February 1, 2001; 73(2): 451S - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Bird, T. Hayakawa, Y. Marsono, J. M. Gooden, I. R. Record, R. L. Correll, and D. L. Topping Coarse Brown Rice Increases Fecal and Large Bowel Short-Chain Fatty Acids and Starch but Lowers Calcium in the Large Bowel of Pigs J. Nutr., July 1, 2000; 130(7): 1780 - 1787. [Abstract] [Full Text] |
||||
![]() |
T. Morita, S. Kasaoka, A. Oh-hashi, M. Ikai, Y. Numasaki, and S. Kiriyama Resistant Proteins Alter Cecal Short-Chain Fatty Acid Profiles in Rats Fed High Amylose Cornstarch J. Nutr., July 1, 1998; 128(7): 1156 - 1164. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||